1.Liver stem cells.
Chinese Journal of Hepatology 2003;11(3):187-189
Animals
;
Cell Differentiation
;
Fetus
;
cytology
;
Hematopoietic Stem Cells
;
cytology
;
Hepatocytes
;
cytology
;
Humans
;
Liver
;
cytology
;
Stem Cells
;
cytology
;
physiology
2.Characteristics of microsomal phase II metabolic enzymes in mouse embryonic stem cell-derived liver tissue.
Tong LI ; Mei-Yuan GUO ; Kui-Fen MA ; Yue DU ; Liang-Yan HE ; Dan-Yan ZHU ; Yi-Jia LOU
Journal of Zhejiang University. Medical sciences 2013;42(5):530-537
OBJECTIVETo investigate the characteristics of phase II metabolic enzymes in mouse embryonic stem (ES) cell-derived liver tissue.
METHODSMature hepatocytes were differentiated from embryonic stem cells in cultured mouse embryoid bodies (EB) at d18. Western blot was used to detect the expression of uridine 5'-diphosphate glucronosyl transferase (UGT1a1,UGT1a6) and microsomal glutathione S-transferases 1(mGST1) during the differentiation course.The derived liver tissue was incubated with UDPGA and 7-HFC,the formation of 7-HFC glucuronide was detected by HPLC to examine the total activities of UGT1a1 and UGT1a6. Furthermore, the microsomes were incubated with CDNB and GSH,and the mGST1 activity was measured by spectrometry.
RESULTSAn increase tendency of UGT1a1 expression was noticed during the differentiation course. UGT1a6 and mGST1 were not detected in the earlier stage until d18 of differentiation. The metabolic activity of mGST1 in the derived hepatocytes was 7.65 nmol/min/mg on d18.
CONCLUSIONThe ES cell-derived liver tissue possesses partial metabolic function of phase II enzymes on d18 of differentiation,which might be used as a model for in vitro research on hepatic pathophysiology and phase II drug metabolism.
Animals ; Cell Differentiation ; Embryoid Bodies ; cytology ; Embryonic Stem Cells ; cytology ; Glucuronosyltransferase ; physiology ; Glutathione Transferase ; physiology ; Hepatocytes ; cytology ; enzymology ; Mice
3.The regulatory mechanism of liver oval cell differentiation.
Chinese Journal of Hepatology 2005;13(12):951-953
Cell Differentiation
;
physiology
;
Cytokines
;
metabolism
;
Hepatocytes
;
cytology
;
Humans
;
Stem Cells
;
cytology
4.Cell sheet fabrication of hepatocyte-like cells differentiated from adipose tissue mesenchymal stem cells.
Yongbo LU ; Feng QIU ; Yongzhu CHEN ; Xiaojun ZHAO
Chinese Journal of Biotechnology 2009;25(4):599-604
Adult pluripotent stem cells, such as mesenchymal stem cells derived from bone marrow and adipose tissue are capable of multilineage differentiation. Although autologous stem cell transplantation is an effective alternative to organ transplantation, the loss of cell viability and differentiation confinement of implanted cells has largely impaired the therapeutic efficacy. To produce biomaterial-free liver construct to integrate into living tissue, we isolated adipose mesenchymal stem cells and subjected them to a delicate culture configuration to mediate the hepatocyte differentiation. The differentiated hepatocyte-like cells were then inoculated onto poly (N-isopropylacrylamide) (PNIPAAm) grafted cell culture dish. By lowering the culture temperature to 20 degrees C, cells detached from the dish surface into a complete cell sheet. Hematoxylin and eosin staining and immunohistochemistry results showed that cell sheet was composed of 2-3 layers of cells and extracellular matrix was maintained intact. As compared with traditional cell harvest using trypsin digestion, cell sheet fabrication causes no damage to cell membrane and extracellular matrix. Hence, cell sheets would form a better interaction with tissues in situ, and a higher cell viability and therapeutic efficiency would be expected.
Adipose Tissue
;
cytology
;
Animals
;
Cell Differentiation
;
physiology
;
Cells, Cultured
;
Hepatocytes
;
cytology
;
Mesenchymal Stromal Cells
;
cytology
;
Rats
;
Tissue Engineering
;
methods
6.Advances in the research of differentiation of embryonic stem cells into hepatocytes.
Qing-Jun ZHOU ; Jian-Zhong SHAO ; Li-Xin XIANG ; Ming ZHANG ; Yong-Liang LU ; Hang YAO ; Li-Cheng DAI
Chinese Journal of Biotechnology 2005;21(2):171-176
Orthotopic liver transplantation has proven to be effective in the treatment of a variety of life-threatening liver diseases, however, the limitations of donated organs available and long-term immunosuppression provided an impetus for developing alternative therapies. Cell replacement strategies have been one major effective approach for overcoming the obstacles of organ transplantation in recent years. The exogenous cells should be able to proliferate and differentiate into mature hepatic cells after grafting. Use of mature hepatocytes is also hampered by limited tissue source and inability to proliferate and maintain the function for a long term in vitro. Embryonic stem cells are immortal and pluripotent and may provide a novel cell source for potential cell therapy. This review summarizes the mechanisms of controlling early liver development and hepatic differentiation of visceral endoderm in embryoid bodies, and provides an overview of diverse differentiation systems in vitro and in vivo that were applied to hepatic research in recent years. Several studies have demonstrated that ES cell-derived hepatocytes can incorporate into liver tissue and function in vivo , but a few of them have shown complete restoration of liver function after transplantation into mice with liver diseases. Further studies should be made to exploit efficient methods and clinical applications of hepatocytes derived from ES cells in the future. In addition to clinical transplantation for treatment of liver diseases, ES cells can provide a valuable tool for drug discovery applications and study on of molecular basis of hepatic differentiation.
Animals
;
Cell Differentiation
;
physiology
;
Cells, Cultured
;
Embryonic Stem Cells
;
cytology
;
transplantation
;
Hepatocytes
;
cytology
;
Humans
;
Liver Diseases
;
therapy
7.Study of embryonic stem cells induced to express hepatic cell functions in vitro in a pathologic niche containing cholestatic serum.
Tian-Ling FANG ; Jun MIN ; Xiao-Geng DENG ; Shi-Kun QIAN ; Zhong-Hua CHU ; Ya-Jin CHEN ; Jing SHAO ; Jing WEI ; Ji-Sheng CHEN
Chinese Journal of Hepatology 2004;12(12):726-729
OBJECTIVETo study the role of a pathologic niche inducing mouse embryonic stem cells (ESC) to express hepatic cell functions in vitro.
METHODSEmbryoid bodies were developed from 5 to 7 day hanging-drop culture of mouse ESC, and their dissociated cells were planted in three differential systems: nothing added; with 20 ng/ml hepatocyte growth factor (HGF); and 5% rat cholestatic serum plus 20 ng/ml HGF added. Their differentiation was observed with inverted microscopes daily, and their hepatic functions were analyzed against their synthesis of glycogen, triglycerides, albumin, and urea nitrogen, and by their staining of indocyanine green (ICG) and fluorescein diacetate (FDA).
RESULTSESC spontaneous differentiation was hardly being controlled to form three germ layers. HGF prompted the ESC to develop further into visceral endoderm and mesoderm (myocardium), but both of them only expressed a low level of hepatocyte-specific metabolic functions. With cholestatic serum added into the HGF-induced system, differentiated cells grew into similar angular cells, and had a higher level synthesis of glycogen, triglycerides, albumin and urea nitrogen with positive ICG and FDA staining.
CONCLUSIONSSpontaneous or HGF-induced ESC differentiation has only limited hepatic functions expressed. A pathologic niche in vitro induces ESC to develop into hepatic lineages, with a higher level of hepatic metabolic functions.
Animals ; Cell Differentiation ; physiology ; Cells, Cultured ; Cholestasis ; blood ; Culture Media ; pharmacology ; Embryo, Mammalian ; Hepatocytes ; cytology ; Mice ; Serum ; Stem Cells ; cytology
9.Preparation of hollow fiber bioreactor for culturing pig hepatocytes.
Ying-jie WANG ; Hong-ling LIU ; Hai-tao GUO ; Jun LIU ; Hong-wei WEN ; Yu-ming WANG
Chinese Journal of Hepatology 2003;11(6):358-360
OBJECTIVETo study the method of preparing the hollow fiber bioreactor for culturing pig hepatocytes.
METHODSHepatocytes were isolated from experimental suckling minipigs by two-step perfusion with collagenase, and seeded onto hollow fiber bioreactor, then cultured with an artificial capillary cell culture system. The albumin-excretion, lidocaine-transforming rate, lactate dehydrogenase (LDH) release and the cell viability in bioreactors were examined.
RESULTSThe porcine albumin could be detected by SDS/PAGE on the 2nd, 4th, 6th day. The rates of lidocaine-transforming ranged from 89.6% to 96.1%. The release of LDH into the culture medium increased from (23.7+/-4.6) U/L to (127.8+/-17.4) U/L (F=39.582, P<0.01) during the experiments, and the viability of pig hepatocytes in hollow fiber bioreactor reduced from 95.8%+/-0.3% to 83.8%+/-4.7% (t=5.135, P<0.01).
CONCLUSIONThe hollow fiber bioreactor for culturing pig hepatocytes can be prepared by artificial capillary cell culture system, which provides a certain liver-specific function in 1 week.
Animals ; Bioreactors ; Biotechnology ; Cells, Cultured ; Female ; Hepatocytes ; cytology ; Liver ; cytology ; physiology ; Liver, Artificial ; Male ; Swine ; Swine, Miniature
10.Hepatic differentiation from embryonic stem cells in vitro.
Anbin HU ; Jiye CAI ; Qichang ZHENG ; Xiaoqing HE ; Yunlong PAN ; Lingsong LI
Chinese Medical Journal 2003;116(12):1893-1897
OBJECTIVETo investigate an method for hepatic differentiation from embryonic stem cells (ES cells) in vitro and the resulting differentiation ratio, in order to develop a procedure for producing a new type of hepatocyte for hepatocyte replacement therapy in the treatment of liver failure.
METHODSES cells from Balb/C mice were cultured and maintained in an undifferentiated state in gelatin-coated dishes using Dulbecco's modified Eagle's medium (DMEM) containing 1000 U/ml leukemia inhibitory factor (LIF). Then, LIF was withdrawn from the DMEM to allow the ES cells to develop into embryonic bodies (EBs). EBs were plated onto tissue culture dishes, and growth factors such as acidicfibroblast growth factor (aFGF) and hepatocyte growth factor (HGF) were added to the medium to promote directional differentiation. The course of development and differentiation was observed dynamically using an inversion microscope. The expression of hepatic proteins, such as alpha-fetoprotein (AFP), albumin (ALB), cytokeratin 8 (CK8), cytokeratin 18 (CK18), in cytoplasm was analyzed by immunocytochemistry (ICC). The concentration of ALB in the medium was determined dynamically by radioimmunoassay (RIA).
RESULTSES cells replicated as clones, without differentiating, in DMEM containing LIF. They developed into EBs in medium without LIF. Our ICC assay showed that differentiating cells did not express hepatic proteins, such as AFP, ALB, CK8, and CK18 until day 7, day 9, day 11, and day 11, respectively (up to 2 days later when growth factors are not present). The concentration of AFP in the medium was first detected on day 8, at a concentration of 3.4 ng/ml, and increased to 22.8 ng/ml by day 15. The concentration of ALB in the medium was 0.2 micro g/ml on day 11, and increased to 2.2 micro g/ml by day 15. ALB-positive cells under ICC manifest morphological structures were consistent with normal mouse hepatocytes. The differentiation ratio of hepatocytes in the ES cell differentiation system was 30% on day 15 (significantly lower without the presence of growth factors).
CONCLUSIONSES cells can differentiate into mature hepatocytes. Growth factors, such as aFGF and HGF, can enhance this differentiation and produce sufficient numbers of functional hepatocytes. This method may be a reliable new way of differentiating ES cells into hepatocytes for use in replacement therapy in the treatment of liver failure.
Animals ; Cell Differentiation ; physiology ; Cells, Cultured ; Embryo, Mammalian ; cytology ; Hepatocytes ; cytology ; Liver ; cytology ; Mice ; Mice, Inbred BALB C ; Stem Cells ; cytology